Sanara MedTech SMTI 深 沪
已收盘 08-21 16:00:00 美东时间
34.45
+0.210
+0.61%
华盛通- 最 高34.45
- 今 开34.29
- 成交量 38.89万股
- 最 低 34.22
- 昨 收 34.24
- 总市值 3.17亿
- 52周最高 35.95
- 市盈率 静 --
- 换手率 4.23%
- 52周最低 16.0465
- 委 比 51.32%
- 总股本 918.80万
- 历史最高 53.85
- 量 比 1.08
- 振 幅 0.67%
- 历史最低 16.0465
- 每 手 1
- 风险率 5.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sanara MedTech Q2 EPS $(0.05) Misses $0.02 Estimate, Sales $28.137M Miss $28.950M Estimate
Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.02 by 350 percent. This is a 78.26 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $28.137 million w...
08-12 04:24
Are MKTX, SMTI, FBRX, LXFR Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
08-07 03:48
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
HC Wainwright & Co. Downgrades Sanara MedTech to Neutral, Lowers Price Target to $35
HC Wainwright & Co. analyst Yi Chen downgrades Sanara MedTech (NASDAQ:SMTI) from Buy to Neutral and lowers the price target from $36 to $35.
07-30 19:15
Sanara Medtech Ends Previously Announced Services Agreement With The Catalyst Group; Not Obliged To Pay Penalty Over Agreement Termination
https://www.sec.gov/ix?doc=/Archives/edgar/data/714256/000149315226027274/form8-k.htm
06-05 04:30
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Ernexa Therapeutics (NASDAQ:ERNA) stock moved upwards by 79.4% to $12....
05-13 01:06
Sanara MedTech shares are trading higher after the company reported better-than-expected Q1 financial results.
Sanara MedTech shares are trading higher after the company reported better-than...
05-12 21:28
Transcript: Sanara MedTech Q1 2026 Earnings Conference Call
Sanara MedTech (NASDAQ:SMTI) held its first-quarter earnings conference call on...
05-12 20:23
Sanara MedTech Sees Q2 Sales $28.500M-$29.500M vs $28.650M Est
Sanara MedTech (NASDAQ:SMTI) sees Q2 sales of $28.500 million-$29.500 million vs $28.650 million analyst estimate.
05-12 05:19
Sanara MedTech Q1 EPS $0.05 Beats $(0.04) Estimate, Sales $27.799M Beat $26.800M Estimate
Sanara MedTech (NASDAQ:SMTI) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.04) by 225 percent. This is a 112.2 percent increase over losses of $(0.41) per share from the
05-12 05:12
